Evidence map›Paper›PMID 38789854›Full record

ArticleRadiologie (Heidelberg, Germany)2024

[Imaging of pancreatic neuroendocrine tumors].

Frank Berger, Maria Ingenerf, Christoph J Auernhammer, Clemens Cyran, Ricarda Ebner, Mathias Zacherl, Jens Ricke, Christine Schmid-Tannwald

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Radiologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Frank BergerKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland.
Maria IngenerfKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland.
Christoph J AuernhammerMedizinische Klinik und Poliklinik 4, Klinikum der Universität München, LMU München, München, Deutschland.
Clemens CyranKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland.
Ricarda EbnerKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland.
Mathias ZacherlKlinik für Nuklearmedizin, Klinikum der Universität München, LMU München, München, Deutschland.
Jens RickeKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland.
Christine Schmid-TannwaldKlinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, München, Deutschland. christine.schmid-tannwald@med.uni-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroendocrine tumors of the pancreas have a broad biological spectrum. The treatment decision is based on an optimal diagnosis with regard to the local findings and possible locoregional and distant metastases. In addition to purely morphologic imaging procedures, functional parameters are playing an increasingly important role in imaging.

objectivesPrerequisites for optimal imaging of the pancreas, technical principles are provided, and the advantages and disadvantages of common cross-sectional imaging techniques as well as clinical indications for these special imaging methods are discussed. MATERIALS AND

methodsGuidelines, basic and review papers will be analyzed.

resultsNeuroendocrine tumors of the pancreas have a broad imaging spectrum. Therefore, there is a need for multimodality imaging in which morphologic and functional techniques support each other. While positron emission tomography/computed tomography (PET/CT) can determine the presence of one or more lesions and its/their functional status of the tumor, magnetic resonance imaging (MRI) efficiently identifies the location, relationship to the main duct and the presence of liver metastases. CT allows a better vascular evaluation, even in the presence of anatomical variants as well as sensitive detection of lung metastases.

conclusionsKnowledge of the optimal combination of imaging modalities including clinical and histopathologic results and dedicated imaging techniques is essential to achieve an accurate diagnosis to optimize treatment decision-making and to assess therapy response.

Indexed as

Magnetic Resonance ImagingNeuroendocrine TumorsPancreatic NeoplasmsHumansMultimodal ImagingPositron Emission Tomography Computed TomographyTomography, X-Ray ComputedComputed tomographyMagnetic resonance imagingPNETPositron emission tomography/computed tomographySomatostatin receptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.